modMD

• Appointment required for participation in the program.
• Limit of 1 purchase per person.
• Must sign a waiver before starting the program.
• Consultation is required; non candidates and refund requests will be honored before service is provided.
• This Fyndr purchase covers the first month only.
• After the first month, the program continues at a rate of $299 per month.
• Shipping costs are included in the purchase price.
• For more information call us at 833-663-6399 or email at info@modmd.com.

Are you ready to achieve your weight loss goals with the latest, most effective programs available? Look no further than Mod MD's innovative weight loss solutions.

What We Offer

One Month Virtual or In Clinic Semaglutide or Tirzepatide Weight Loss Programs (0.25mg or 2.5mg)

• Tailored Virtual Consultation: Experience the convenience of a 100% online consultationwith their expert physicians.
• First Month of Medication Included: Witness tangible results and take the first step towards a healthier, happier you.
• Unlimited Follow Up Messaging: Stay connected with your doctor every step of the way.Receive continuous support, guidance, and motivation to keep you on track toward your weight management goals.
• Priority Support: Their dedicated agents are available via phone, email, and chat from Monday to Friday, ensuring prompt assistance whenever you need it. Feel empowered knowing that help is just a message away.
• Fast Shipping: Once approved, your order ships in 5 business days or less.
• Benefits: Explore the benefits that target biological factors impeding weight management, suppress appetite to promote lasting fullness, and aid in controlling blood sugar levels for enhanced overall health.

Virtual weight loss services are only available to residents of the following states:

• Arizona
• Colorado
• Florida
• Georgia
• New Jersey
• New York
• Oregon
• Texas
• Utah
• Virginia

Both Semaglutide and Tirzepatide will not be prescribed to individuals with the following conditions:

• BMI under 27
• Eating disorders, gallbladder disease, drug/alcohol abuse.
• Recent bariatric surgery, pancreatitis, or medullary thyroid cancer.
• Currently pregnant, breastfeeding, or planning pregnancy.
• Diabetic retinopathy, Multiple endocrine neoplasia type 2, or family history of medullary thyroid carcinoma.